<em>Decision-IQ</em>: Management of HER2-Positive Breast Cancer With Brain Metastases: A Case-Based Activity
Decision-IQ Decision-IQ

Decision-IQ: Management of HER2-Positive Breast Cancer With Brain Metastases: A Case-Based Activity


This activity was developed by Med-IQ in collaboration with Duke Health.

Med-IQ      Duke Medicine
 

Released:
12/9/19
Expires:
12/8/20

Maximum Credits:

0.25
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Decision-IQ Decision-IQ
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
12/9/19

Expires:
12/8/20

Maximum Credits:
0.25
Decision-IQ Decision-IQ
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
12/9/19
Expires:
12/8/20


Maximum Credits:
0.25


Overview:

In this brief, case-based activity, meet a 42-year-old woman with a history of human epidermal growth factor 2 (HER2)-positive breast cancer that metastasized to the brain while she was receiving systemic therapy.

As you move through this activity, you will:

  • Be directed to useful resources to help you make clinical decisions about managing her systemic and intracranial disease
  • See how your answers compare with your peers’
  • Receive insights from medical oncologist Carey Anders, MD, and neurosurgeon Peter Fecci, MD, PhD, about the systemic treatment of metastatic, HER2-positive breast cancer and the assessment and management of brain metastases

CME Information:

Faculty
Carey Anders, MD 
Medical Director, DCI Center for Brain and Spine Metastasis 
Member, Breast Medical Oncology Group 
Duke University Medical Center 
Durham, NC

Peter E. Fecci, MD, PhD 
Associate Professor, Neurosurgery 
Director, Duke Center for Brain and Spine Metastasis 
Residency Program Director, Neurosurgery 
Duke University Medical Center 
Durham, NC 
 
Activity Planners
Lori Pender, PharmD, MPH, BCOP
Manager, Educational Strategy and Content
Med-IQ
Baltimore, MD

Laura Rafferty, ELS
Managing Editor
Med-IQ
Baltimore, MD

Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD

Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
Med-IQ
East Lansing, MI 
 
Learning Objectives
Upon completion, participants should be able to:

  • Select appropriate therapy for the management of metastatic, HER2-positive breast cancer with brain metastases

Target Audience
This activity is intended for medical, surgical, and radiation oncologists and neurosurgeons. 

Statement of Need
Brain metastases are a devastating complication of HER2-positive breast cancer. Because systemic therapies have improved in recent years, patients are living longer than ever, increasing both the need for and complexity of intracranial disease management. Challenges include the lack of a robust evidence base, need for multidisciplinary collaboration, and difficulties distinguishing intracranial progression from radiation necrosis in previously treated patients. Oncologists and neurosurgeons who care for these patients must be able to overcome these challenges to optimize outcomes for patients with metastatic, HER2-positive breast cancer.

Collaboration Statement
This activity was developed by Med-IQ in collaboration with Duke Health.
 
Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Med-IQ designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
 
Medium/Method of Participation
This CME activity consists of a 0.25-credit online publication. To receive credit, read the introductory CME material, read the publication, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
 
Initial Release Date: December 9, 2019
Expiration Date: December 8, 2020
Estimated Time to Complete This Activity: 15 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 
 
Carey Anders, MD 
Consulting fees/advisory boards: Eisai Inc., Genentech, Ipsen
Contracted research: G1 Therapeutics, Inc., Lily USA, LLC, Merck & Co., Inc., Nektar, Seattle Genetics, Tesaro 

Peter E. Fecci, MD, PhD 
Consulting fees/advisory boards: Monteris Medical

The peer reviewers and activity planners have no financial relationships to disclose.
 
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
 
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
 
Contact Information        
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.

System Requirements

Desktop

Mobile

  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)

Applications & Software

For technical assistance, please refer to our Support Manual.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.
 
Copyright
© 2019 Med-IQ, Inc. and Duke University Health System

 

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.

We recently updated our Privacy Notice and Terms of Use.